Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961

To assess the impact of minimally differentiated acute myeloid leukemia (AML-M0) morphology in children, we analyzed 2 sequential Children's Cancer Group AML clinical trials. We compared presenting characteristics and outcomes of 82 CCG-2891 and CCG-2961 patients with de novo, non–Down syndrome...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Barbaric, Draga, Alonzo, Todd A., Gerbing, Robert B., Meshinchi, Soheil, Heerema, Nyla A., Barnard, Dorothy R., Lange, Beverly J., Woods, William G., Arceci, Robert J., Smith, Franklin O.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2007
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852193/
https://ncbi.nlm.nih.gov/pubmed/17158236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-11-025536
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk